MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Strona główna・Stock List・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Closed

SectorHealthcare

6.63 0.61

Buy Sell

Overview

Share price change

24h

Current

Min

6.51

Max

6.73

Key metrics
By Trading Economics
Income	30M -36M
Sales	1.6M 31M
Profit margin	-117.018
Employees	181
EBITDA	24M -40M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+309.13% upside

Dividends
By Dow Jones
Next Earnings	29 lip 2025

Market Stats
By TradingEconomics
Market Cap	-132M 672M
Previous open	6.02
Previous close	6.63

News Sentiment

By Acuity

50%

154 / 376 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

6.26 / 7.47 Support & Resistance

Day One Biopharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 lip 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 lip 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 lip 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 lip 2025, 20:07 UTC

Earnings

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 lip 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 lip 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 lip 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 lip 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 lip 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 lip 2025, 18:32 UTC

Acquisitions, Mergers, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 lip 2025, 18:31 UTC

Acquisitions, Mergers, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 lip 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 17:25 UTC

Acquisitions, Mergers, Takeovers

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 lip 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 lip 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Peer Comparison

Price change

Day One Biopharmaceuticals Inc Forecast

Price Target

By TipRanks

309.13% upside

12 Months Forecast

Average 26.88 USD 309.13%

High 36 USD

Low 18 USD

Based on 9 Wall Street analysts offering 12 month price targets forDay One Biopharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Day One Biopharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

6.26 / 7.47Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

154 / 376 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.